| Financial Year |
March 31 2023 |
| Monetary Funds |
81,334,369.66 |
| Held-for-trading Financial Assets |
3,300,000.00 |
| Notes Receivable |
66,521,289.35 |
| Accounts Receivable |
99,941,430.71 |
| Advances to Suppliers |
40,852,119.79 |
| Other Receivables |
4,932,351.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
539,134,872.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,226,160.19 |
| Total Current Assets |
859,838,768.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
255,299,535.46 |
| Investment Properties |
105,167,266.40 |
| Fixed Assetes |
659,739,176.21 |
| Under-construction Projects |
16,734,287.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,681,875.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,779,847.97 |
| Deferred Income Tax Assets |
130,912,330.63 |
| Other Non-Current Assets |
3,783,954.02 |
| Sub-Total of Non-Current Assets |
1,718,575,844.20 |
| Total Assets |
2,578,414,612.25 |
| Short-Term Loans |
596,774,317.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
16,410,000.00 |
| Accounts Payable |
116,451,796.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,254,311.56 |
| Taxes Payable |
18,052,824.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
220,764,505.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,891,105.79 |
| Other Current Liabilities |
64,218,149.68 |
| Sub-Total of Current Liabilities |
1,077,580,741.86 |
| Long-term Loans |
30,029,349.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
35,392,314.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
121,504,427.69 |
| Total Liabilities |
1,199,085,169.55 |
| Paid-In Capital(Or Share Stock) |
620,570,400.00 |
| Capital Surplus |
1,859,702,766.08 |
| Surplus Reserve |
62,433,974.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,151,297,016.73 |
| Minority Stockholder's Interest |
-14,027,282.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,393,356,724.92 |
| Owner's Equity（Stockholder's Equity） |
1,379,329,442.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,578,414,612.25 |
